Viatris positive on outlook for insulin biosimilar
August 09, 2021 at 14:38 PM EDT
The product will be available by the end of the year and will be exclusive for 12 months.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|